Filing Details

Accession Number:
0001628280-23-007375
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-09 17:24:03
Reporting Period:
2023-03-07
Accepted Time:
2023-03-09 17:24:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1588978 Procept Biorobotics Corp PRCT Surgical & Medical Instruments & Apparatus (3841) 260199180
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1653771 Kevin Waters C/O Procept Biorobotics Corporation
900 Island Drive
Redwood City CA 94065
Evp, Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-03-07 7,136 $34.15 79,724 No 4 S Direct
Common Stock Disposition 2023-03-08 22,046 $34.36 57,678 No 4 S Direct
Common Stock Disposition 2023-03-07 818 $35.16 56,860 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.0000 to $34.7400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.0000 to $34.9925, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.0000 to $35.3600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.